The successful training program in Bioinformatics and Integrative Genomics (BIG) has been transferred from the MIT-Harvard Division of Health Sciences and Technology to the Harvard Medical School Division of Medical Sciences (DMS). This entails incremental changes in the curriculum, because of full cross-registration and a change in focus of the clinical experience away from general physiology and towards medical genetic clinics, and clinical genetics laboratory experience. BIG continues to focus on the growing gap between the ability to generate copious amounts genomic data and the ability to systematically and efficiently make sense of all this data, particularly for clinical relevance. Ths program admits students with proven excellence in quantitative science and seeks to train competent, multi-disciplinary investigators who are capable of both integrating the genome-scale technologies into their experimental investigations, and synthesizing the resulting datasets into coherent knowledge frameworks and mathematical models for formulating and resolving fundamental questions in biology and medicine. The BIG training program draws on three significant strengths of the local academic environment: the breadth of talented investigators at Harvard, the Medical School and affiliated hospitals, and MIT, the rich variety of quantitatively-oriented courses in advanced genomics-bioinformatics offered at Harvard and MIT, and national leadership of BIG faculty in harnessing clinical processes and electronic health records for genome-scale disease research. As a new track within DMS, the BIG pre-doctoral program provides a three legged curriculum: 1) rigorous course work in machine learning, probability theory, decision science, and biostatistics 2) in-depth courses that include the range of genome-scale measurements applied to population studies, clinical medicine and basic biology 3) survey of the larger scope of biomedical sciences as well as a rich, unique clinical experience focused on genetics clinics and genetic laboratory testing.

Public Health Relevance

Integrating genomics into the practice of medicine and biomedical research is a primary goal of the National Human Genome Research Institute's strategic plan. The Harvard University Bioinformatics and Integrative Genomics (BIG) Program meets this goal by providing students trained in the quantitative sciences the intellectual tools t integrate genomics with medical science, access to big data from healthcare systems to experiment with methods of leveraging healthcare data in genomic science, faculty who are leading efforts to integrate genome-scale results into clinical practice, and faculty who are expert in genomics and bioinformatics.

National Institute of Health (NIH)
National Human Genome Research Institute (NHGRI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Ethical, Legal, Social Implications Review Committee (GNOM)
Program Officer
Gatlin, Christine L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Harvard Medical School
Schools of Medicine
United States
Zip Code
Stokes, Patrick A; Purdon, Patrick L (2017) A study of problems encountered in Granger causality analysis from a neuroscience perspective. Proc Natl Acad Sci U S A 114:E7063-E7072
Chan, Yingleong; Tung, Michael; Garruss, Alexander S et al. (2017) An unbiased index to quantify participant's phenotypic contribution to an open-access cohort. Sci Rep 7:46148
Wala, Jeremiah; Beroukhim, Rameen (2017) SeqLib: a C?++ API for rapid BAM manipulation, sequence alignment and sequence assembly. Bioinformatics 33:751-753
Collins, Ryan L; Brand, Harrison; Redin, Claire E et al. (2017) Defining the diverse spectrum of inversions, complex structural variation, and chromothripsis in the morbid human genome. Genome Biol 18:36
Villani, Alexandra-Chloé; Satija, Rahul; Reynolds, Gary et al. (2017) Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356:
Abelin, Jennifer G; Keskin, Derin B; Sarkizova, Siranush et al. (2017) Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction. Immunity 46:315-326
Kosmicki, Jack A; Samocha, Kaitlin E; Howrigan, Daniel P et al. (2017) Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples. Nat Genet 49:504-510
Brown, Adam S; Patel, Chirag J (2017) A standard database for drug repositioning. Sci Data 4:170029
Manrai, Arjun K; Funke, Birgit H; Rehm, Heidi L et al. (2016) Genetic Misdiagnoses and the Potential for Health Disparities. N Engl J Med 375:655-65
Wala, Jeremiah; Beroukhim, Rameen (2016) CANCER. The oncogene makes its escape. Science 351:1398-9

Showing the most recent 10 out of 70 publications